...The three market-implied ratings for Amgen have followed different paths recently. However, in the first trading day following the company s July 29 announcement -- that second quarter earnings rose 23%, management increased 2014 revenue and earnings guidance, and there would be a workforce reduction of 12% to 15% -- market signals were unchanged. The bond-implied rating, which was A2 90 days ago, fell by one notch to A3 (Figure 1). The CDS- implied rating, also A2 90 days ago, moved up to as high as Aa3, but has now retreated back to A2. The EDF...